Metabolic disorders Flashcards

1
Q

Case
CC: Poor weight Gain
K.A. 3mo/F , sees you for the first time with the chief complaint of
poor weight gain.
Pertinent in the birth history is history of
(+) feeding difficulties with frequent vomiting episodes
(+) prolonged jaundice
(+) poor weight gain
(+) history of seizures
Newborn screening: (+)
Nutritional History: Exclusively breastfed
PE:
Weight for age below -3 , Length for age below -3
lethargic , generalized hypotonia, (+) jaundice
(+) bilateral cataracts
(+) hepatomegaly
(+) splenomegaly
Laboratory:
CBC: WBC 9.0 Hgb 145 Hct .45 plt
Blood CS: NG5D
RBS: low
ABG: metabolic acidosis
Babygram: Normal chest, hepatomegaly, paucity of bowel pattern

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary impression?

A

Galactosemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the basis for the primary impression?

A

Basis:
Typical signs and Symptoms at Birth/ Hx
o feeding difficulties with frequent vomiting episodes
o prolonged jaundice
o poor weight gain
o history of seizures
o Newborn screening: (+)
Physical findings
o Poor growth within the first few weeks of life
o Jaundice
o Bleeding from coagulopathy
o Liver dysfunction and/or hepatomegaly
o Cataracts (sometimes as early as the first few days of
life)
o Lethargy
o Hypotonia
o Sepsis (E coli)
Lab Results:
o NBS (+) Galactosemia
o RBS: low
o ABG: metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the differentials?

A
  1. Sepsis/ TORCH
    Rule in:
    Vomiting, poor feeding
    Poor weight gain
    seizures
    Cataracts, Hepatosplenomegaly -
    TORCH
    Galactosemia patients are at
    increased risk for E. coli sepsis

Rule out:
(+) NBS: Galactosemia
jaundice WBC normal, Blood CS: NG

  1. IEM
    Rule in:
    Vomiting, poor feeding
    jaundice
    Poor weight gain
    seizures
    ABG: metabolic acidosis
    RBS: low

Rule out:
(+) NBS: Galactosemia

  1. GERD
    Rule in: Vomiting, poor feeding (+)
    Poor weight gain
    Severely wasted, severe
    stunted

Rule out:
NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly

4.GI malformations: (Atresia, pyloric stenosis)
Rule in:
Vomiting, poor feeding
Poor weight gain
Severely wasted, severe
stunted

Rule out:
(+) NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly
Babygram: Paucity of gas bowel
patterns

  1. RTA
    Rule in:
    Vomiting, poor feeding
    Poor weight gain
    Severely wasted, severe
    stunted
    ABG: metabolic acidosis

Rule out:
(+) NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

work-up

A

o A positive (ie, abnormal) indication on the newborn
screen must be followed by a Direct enzyme assay
using erythrocytes which shows Deficient activity of
galactose-1-phosphate uridyl transferase
demonstrable in hemolysates of erythrocytes, which
also exhibit increased concentrations of galactose-1-
phosphate
Additional in work up for cases of FTT:
o Basic work-up may include CBC (for anemia), Blood
gas (RTA, metabolic disease), TFTs, UA
o (renal and metabolic disease), ESR/CRP (sign of
inflammation/infection), stool for fat, pH, reducing
o substances, occult blood, ova and parasites, sweat
chloride, lead, TB and HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment

A

Treatment:
o Early diagnosis and treatment have improved the
prognosis of galactosemia
o Elimination of galactose from the diet reverses growth
failure and renal and hepatic dysfunction.
o Various milk substitutes are available (casein
hydrolysates, soybean-based formula).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prognosis

A

Prognosis:
o Most patients with severe galactosemia who do not
receive treatment often do not survive the newborn
period. Even with appropriate dietary therapy, most
patients have at least 1-2 long-term complications
(ovarian failure with primary or secondary
amenorrhea, decreased bone mineral density,
developmental delay, and learning disabilities that
increase in severity with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acidic urine odor

A

Methylmalonic acidemia (methylmalonic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cabbage urine odor

A

hepatorenal tyrosinemia, methionine malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cat urine

A

3-methylcrotonyl CoA dehydrogenase deficiency, multiple carboxylase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Maple syrup/burnt syrup

A

MSUD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mouse/musty

A

PKU (phenylacetate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

rancid butter

A

hepatorenal tyrosenemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sweaty feet

A

isovaleric acidemia, glutaric aciduria, Type II (Isovaleric acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical approach to a newborn infant with a suspected metabolic disorder

A

p. 178

  1. Clues in Hx:
    - Marriage is consanguineous, hx of recurrent abortion,
    hx of unexplained neonatal death in siblings especially
    assoc with acidosis, coma and convulsions, sibling
    diagnosed suffering an IEM
  2. Clues in PE
    - Tachypnea, apnea, lethargy
    - Hyper/hypotonicity
    - Hepatosplenomegaly, ambiguous genitalia, jaundice
    - Dysmorphic or coarse facial fx
    - Rashes/patchy hypopigmentation
    - Ocular (cataracts, lens dislocation, pigmentary
    retinopathy
    - Intracranial hemorrhage
    - Unusual odors
  3. Laboratory
    a. ABG – metabolic acidosis with inc anion
    gap, primary respiratory alkalosis
    b. Plasma ammonia elev
    c. Hgt – hypoglycemia
    d. Serum and urine ketones – ketosis and
    ketonuria
    e. TB, DB, IB, elev LFTs – hyperbilirubinemia
    f. Lactic acidosis
    g. High lactate/pyruvate ratio
    h. Non-glucose reducing substances in urine
    i. CBC – neutropenia, thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management

A

Mgt
1. Newborn screening - do after the 24th HOL or 48th-72nd HOL. If collected at <24h, repeat at 2 WOL
- In sick children, no later than 7d; NICU test by 7d-1 mo.
- For PT, ideal time should be at 5-7d old
- Prior to providing TPN, blood transfusion or on NPO
- Newborn screening act 2004 or Republic act 9288
o Provide an opportunity for every NB for early identification of conditions that can cause mental retardation or death

17
Q

What is the enzyme defect for congenital hypothyroidism?

A

multiple disorders
CM: appear normal at birth; large fontanelles, jaundice, macroglossia, hypotonic, lethargic, weak cry

18
Q

What is the enzyme defect in CAH?

A

21-hydroxylase deficiency
CM: salt wasting
simple virilizing

19
Q

What is the enzyme defect of phenylketonuria?

A

phenylalanine hydroxylase
PTPS
Normal at birth

20
Q

What is the enzyme defect in galactosemia?

A

Galactose 1 phosphate
Uridyl transferase
Galactokinase
Galactose-4 epimerase

CM: normal at birth, jaundice, feeding intolerance, FTT, hepatomegaly

21
Q

What is the enzyme defect in G6PD deficiency?

A

Glucose-6-phosphate dehydrogenase

CM: normal at birth; jaundice, pallor

22
Q

Golden period

A

CH: 2 weeks
enzyme screened: TSH
Confirmatory: TSH and T4 levels

CAH:
1-2 weeks
enzyme screened: 17-OHP
Confirmatory: 17-OHP quantitative levels

PKU:
2 weeks
enzyme: Phenylalanine
Confirmatory:phenylalanine/tyrosine

Gal: 3 weeeks
enzyme screened: GALT/Gal metabolites
confirmatory: enzyme measurement

G6PD deficiency:
enzyme: G6PD
confirmatory: quantitative enzyme measurement

23
Q

Factors that affect NBS result:

A
  • BT, dialysis, IV abx, PT, NPO since birth
24
Q

Differetials

A

DDx: G6PD deficiency (p.148)
Hypothyroidism (p.125)
Congenital adrenal hyperplasia (p.172)

25
What is Galactosemia? Difference between Classical and non-classical?
GALACTOSEMIA - Classical: deficiency of galactose-1-phosphate uridyl transferase - Non-classical: deficiency in galactokinase or epimerase - Autosomal recessive
26
What are the clinical manifestations of galactosemia?
CM 1. vomiting, jaundice, hepatomegaly, anorexia and FTT 2. sepsis with E.coli 3. lenticular cataract formation 4. MR, pseudotumor cerebri 5. F: ovarian failure 6. Delayed speech and language
27
Management of Galactosemia
Mgt 1. Exclusion of galactose in diet 2. Substitution of casein hydrosylate or soybean preparation
28
What is Phenylketonuria?
PHENYLKETONURIA - Classical: lack on enzyme phenylalanine hydroxylase - PTPS deficiency: lack of co-enzyme 6-pyruvoyltetrahydropterin synthase or tetrahydrobiopterin - Hyperphenylalaninemia
29
Clinical manifestations of Phenylketonuria?
CM 1. N at birth 2. MR (1/3 of pxs) 3. Cerebral palsy (1/3) 4. Mild neurologic signs (1/3)
30
Management of PKU?
Mgt 1. Dietary – giving special milk formula (phenyl-free) 2. Limiting natural protein intake 3. BH4 4. Levodopa 5. 5-HT or serotonin
31
What is MSUD?
MAPLE SYRUP URINE DISEASE - Caused by a defect in the branch chain oxoacid dehydrogenase multienzyme complex
32
What are the different phenotypes of PKU?
1. Classic Age of onset: neonatal CM: maple syrup odor of cerumen, poor feeding, irritability, lethargy, focal dystonia, fencing, "bicycling" -elevated BCAAs in plasma -Elevated plasma allo-isoleucine -elevated BCKAs -positive urine DNPH test -Ketonuria 2. Intermediate age of onset: variable CM: maple syrup odor of cerumen; poor growth, poor feeding, irritability, developmental delays, encephalopathy during illness -similar to classic phenotype though quantitatively less severe 3. Intermittent age of onset: variable CM: normal early growth and development; episodic decompensations that can be severe -normal BCAAs when well -similar to classic biochemical profile during illness 4. Thiamine-responsive age of onset: variable CM: similar to the intermediate phenotype
33
MSUD manifestations
1. 12-24 HOL: maple syrup odor in cerumen, increase in BCAA levels and allo-isoleucin 2. 2-3 DOL: ketonuria, irritability, poor feeding 3. 4-5 DOL: lethargy, opisthotonos, stereotypical movts 4. 7-10d: coma, respiratory failure
34
management
Mgt 1. Dietary management a. Leucine restriction b. Supplement with isoleucine and valine
35
EXPANDED NEWBORN SCREENING
Screen for >28 (35) total IEM disorders o Endocrine disorders – severe MR, death o Amino acid disorders – MR, coma, death from metabolic crisis o FA disorders – devtl and physical delays, neuro impairment, sudden death, coma, sz, cardiomegaly, hepatomegaly, ms weakness o Organic acid disorders – devtl delay, RD, neuro damage, sz, coma, early death o Urea cycle defect – sz, MR, death o Hemoglobinopathies – alpha thalassemia, sickle cell ds § Painful crises, anemia, stroke, MOF, death § NOT beta thal bec physiologic shift of Hgb to adult levels at 6MOL o Others – cystic fibrosis